Gapping down
In reaction to disappointing earnings/guidance: IGT -10.2% (also downgraded to Neutral from Buy at Sterne Agee; tgt lowered to $18 from $21.50), DGII -9.5%, RMD -8.9% (also downgraded to Mkt Perform from Outperform at William Blair), KSU -6.9%, COVS -6.5%, ISRG -5.5%, CST -4% (light volume), AMCC -2.2%, XRX -1.3%, SYNA -0.9%, MXIM -0.8% (upgraded to Positive from Neutral at Susquehanna), HON -0.2%
Select financial related names showing weakness: ING -2.1%, RBS -1.7%, DB -1.5%, C -1.4% (downgraded to Neutral from Overweight at Atlantic Equities), CS -1.3%, UBS -1.2%, BAC -1.1%.
Latin America (including Brazil) names are under pressure: GFA -5.9%, BBVA -4.9%, OIBR -3.9%, TSU -3.5%, BSBR -2.7%, TEF -2.6%, VALE -2.2%, ELP -2.1%, ITUB -2.1%, SAN -1.5%, PBR -1.3%,CIG -1.2%, BBL -1%, BHP -0.6%
Oil/gas names seeing weakness: SDRL -2.2%, STO -2.1%, ESV -1.5% (downgraded to Market Perform from Outperform at Wells Fargo), RIG -1.1% (downgraded to Market Perform from Outperform at Wells Fargo), CHK -1.1%, NE -1% (downgraded to Market Perform from Outperform at Wells Fargo), DO -0.3% (Diamond Offshore downgraded to Market Perform from Outperform at Wells Fargo)... A few coal names are also trading lower: WLT -4% (downgraded to Market Perform from Outperform at Wells Fargo), YZC -3%, BTU -1.2%,
Other news: PTCT -27.5% (announces CHMP of the EMA has adopted a negative opinion on the co's MAA for conditional approval of ataluren for the treatment of nonsense mutation Duchenne muscular dystrophy; co appoints Robert J. Spiegel to Chief Medical Officer), ATOS -18.8% (announces proposed public offering of common stock and warrants), KIPS -14.3% (prices 5.25 mln shares at $0.70 per share), TNXP -5.5% ( announces proposed public offering of common stock, no amount given), BBRY -3.3% (continued weakness following reports that Pentagon has not placed any new orders with BBRY), TSLA -2.8% (modestly pulling back), PGNX -2.7% ( files for $150 mln mixed securities shelf offering), BUD -2.7% (still checking), AA -2.7% (still checking), AIXG -2.3% (still checking), GNVC -2% ( files for $75 mln mixed securities shelf offering), GSK -1.8% (GlaxoSmithKline receives positive opinion from the CHMP in Europe for once-weekly Eperzan (albiglutide) for the treatment of type 2 diabetes; downgraded to Hold from Buy at Berenberg ), TWTR -1.6% (still checking), QIHU -1.4% (following 3 point decline exacerbated by late weakness on reports that Alibaba not taking stake), AAPL -0.5% (following 4+ point move higher, boosted by Icahn letter) .
Analyst comments: MLNX -3.7% (downgraded to Underweight from Equal Weight at Barclays), FEYE -3% (downgraded to Equal Weight from Overweight at Barclays), CMG -1.7% ( downgraded to Neutral from Outperform at Wedbush; initiated with an Outperform at Oppenheimer), ALV -1.5% (downgraded to Underweight from Equal Weight at Barclays), COH -0.7% (downgraded to Hold from Buy at Cantor Fitzgerald),